Shenzhen Edge Medical Co (FRA:R5Z) EV-to-FCF: -66.31 (As of Aug. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:R5Z Shenzhen Edge Medical Co Ltd FRA:R5Z
20 GF Score
Price €4.13
! 3 Warning Signs
View Full Analysis

What is Shenzhen Edge Medical Co EV-to-FCF?

Shenzhen Edge Medical Co FRA:R5Z -0.96% 20 EV-to-FCF is -66.31 as of Aug. 14, 2026. GuruFocus rates FRA:R5Z with a GF Score™ of 20/100. The stock has 3 warning signs investors should review. Among 409 Medical Devices & Instruments companies, Shenzhen Edge Medical Co ranks worse than 244498.53% on this metric.

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Shenzhen Edge Medical Co's Enterprise Value is €1,587.62 Mil. Shenzhen Edge Medical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €-23.94 Mil. Therefore, Shenzhen Edge Medical Co's EV-to-FCF for today is -66.31.

The historical rank and industry rank for Shenzhen Edge Medical Co's EV-to-FCF or its related term are showing as below:

FRA:R5Z' s EV-to-FCF Range Over the Past 10 Years
Min: -119.81   Med: -90.1   Max: -60.3
Current: -65.83

During the past 3 years, the highest EV-to-FCF of Shenzhen Edge Medical Co was -60.30. The lowest was -119.81. And the median was -90.10.

FRA:R5Z's EV-to-FCF is ranked worse than
100% of 409 companies
in the Medical Devices & Instruments industry
Industry Median: 24.41 vs FRA:R5Z: -65.83

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-08-14), Shenzhen Edge Medical Co's stock price is €4.13. Shenzhen Edge Medical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.028. Therefore, Shenzhen Edge Medical Co's PE Ratio (TTM) for today is At Loss.


Shenzhen Edge Medical Co  (FRA:R5Z) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Shenzhen Edge Medical Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=4.13/-0.028
=At Loss

Shenzhen Edge Medical Co's share price for today is €4.13.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Shenzhen Edge Medical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.028.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Shenzhen Edge Medical Co EV-to-FCF Related Terms


Shenzhen Edge Medical Co EV-to-FCF Historical Data

* Premium members only.

The historical data trend for Shenzhen Edge Medical Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shenzhen Edge Medical Co EV-to-FCF Chart

Shenzhen Edge Medical Co Annual Data
Trend Dec23 Dec24 Dec25
EV-to-FCF
0.00 0.00 0.00

Shenzhen Edge Medical Co Semi-Annual Data
Dec23 Jun24 Dec24 Jun25 Dec25
EV-to-FCF 0.00 0.00 0.00 0.00 0.00

FRA:R5Z vs ABT, SYK, MDT: EV-to-FCF Comparison

For the Medical Devices subindustry, Shenzhen Edge Medical Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen Edge Medical Co EV-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shenzhen Edge Medical Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Shenzhen Edge Medical Co's EV-to-FCF falls into.


FRA:R5Z
20GF Score
Shenzhen Edge Medical Co Ltd FRA:R5Z
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shenzhen Edge Medical Co EV-to-FCF Calculation

Shenzhen Edge Medical Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1587.619/-23.943
=-66.31

Shenzhen Edge Medical Co's current Enterprise Value is €1,587.62 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Shenzhen Edge Medical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €-23.94 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-FCF →
What does a EV-to-FCF of -66.31 mean?
Shenzhen Edge Medical Co (FRA:R5Z) has a EV-to-FCF of -66.31 as of Aug. 14, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Shenzhen Edge Medical Co and its competitors. According to the industry distribution chart, Shenzhen Edge Medical Co ranks #999999 out of 409 companies in the Medical Devices & Instruments industry.
Is Shenzhen Edge Medical Co's EV-to-FCF too high?
Shenzhen Edge Medical Co's current EV-to-FCF is -66.31. Based on the distribution chart, Shenzhen Edge Medical Co ranks #999999 out of 409 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Shenzhen Edge Medical Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Shenzhen Edge Medical Co's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shenzhen Edge Medical Co ranks #999999 out of 409 companies for EV-to-FCF. This places Shenzhen Edge Medical Co in the lower half of its industry. The industry median EV-to-FCF is 24.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 24.41, based on 409 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Shenzhen Edge Medical Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 24.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shenzhen Edge Medical Co's current EV-to-FCF is -66.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen Edge Medical Co stock overvalued right now?
Shenzhen Edge Medical Co (FRA:R5Z) has a current EV-to-FCF of -66.31. The current EV-to-FCF is -66.31. Shenzhen Edge Medical Co's overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Shenzhen Edge Medical Co (FRA:R5Z), the current EV-to-FCF is -66.31 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Shenzhen Edge Medical Co Business Description

Other Exchanges 02675:Hong Kong
Address Baolong Street, Room 1901, Building 2B, Smart Park Phase II, Longgang District, Shenzhen, CHN
Shenzhen Edge Medical Co Ltd is principally engaged in the designing, research and development, manufacturing and sale of surgical robots. It has a pipeline of three products and product candidates covering various models at different development stages to capture the market potential in surgical robots, including Edge Multi-Port Endoscopic Surgical Robot and Edge Single-Port Endoscopic Surgical Robot for MIS, as well as Edge Bronchoscope Robot for non-invasive surgery. The company derives revenue principally from the sales of surgical robot systems, instruments and accessories, and provision of services. Geographically, the maximum revenue is generated from the Chinese mainland, followed by Asia (other than Chinese Mainland), Europe, and Others.
20GF Score

Get the complete analysis for FRA:R5Z

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.13
Price